drugset / Trial / NCT01467141

Safety and Efficacy of Insulin Aspart in Children With Type 1 Diabetes

NCT01467141

Phase 4 Completed 26 enrolled Novo Nordisk A/S
RandomizedCrossoverOpen-labelTreatment

Summary

This trial is conducted in Europe. The aim of this trial is to evaluate safety and efficacy in children with type 1 diabetes.

Timeline

Start
2002-06-19
Primary completion
2003-10-15
Completion
2003-10-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic Subcutaneous
Subject insulin aspart Protein / enzyme biologic Subcutaneous
Background isophane human insulin Protein / enzyme biologic Subcutaneous